It is widely perceived that the availability of sensitive and specific biomarkers for the diagnosis and the monitoring of progression of neurodegenerative disorders, sufficiently robust to be used in large multicentric trials, is one of the greatest unmet needs in the field of neurodegenerative disease research.
Therefore, an immediate issue to be addressed is the development of optimally informative biomarkers to provide a solid basis for the establishment of risk-stratified patient cohorts and for upcoming multicentric diagnostic and therapeutic trials and to ensure stakeholder agreement regarding their use.
On 13 May 2011 a JPND joint transnational call was launched between 21 countries, to encourage novel approaches to the development of optimally informative biomarkers and harmonisation of their use. Applications were invited from collaborative consortia of researchers from participating countries.
The call was conducted simultaneously by the participating funding organisations in their respective countries and coordinated centrally, with a single proposal submission and peer review system. The proposal submission deadline was the 5th of September, 2011.
The total fund for this call was over 16 million euro (for all participating countries).
Four projects are currently being funded under this call. Details of individual projects can be found here and via the “Results of 2011 Call” link on the left of this page.
Where can I get more information about this call?
JPND call contact point:
Dr. Constanze Hahn
JPND Joint Call Secretariat
Phone: +49 228 3821 1865